PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
12.09%
Net income growth above 1.5x AVGO's 7.20%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
9.20%
D&A growth well above AVGO's 2.70%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
38.65%
Lower deferred tax growth vs. AVGO's 101.63%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
13.26%
SBC growth well above AVGO's 18.18%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-321.52%
Negative yoy working capital usage while AVGO is 166.67%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-1188.16%
AR is negative yoy while AVGO is 70.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
193.84%
Some inventory rise while AVGO is negative at -2600.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-215.57%
Negative yoy AP while AVGO is 362.50%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-15.91%
Negative yoy usage while AVGO is 87.76%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
74.88%
Well above AVGO's 7.20%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-52.37%
Negative yoy CFO while AVGO is 51.80%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
25.23%
Some CapEx rise while AVGO is negative at -19.15%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
33.67%
Purchases growth of 33.67% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
85.70%
Liquidation growth of 85.70% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-293.47%
We reduce yoy other investing while AVGO is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-8.20%
Both yoy lines negative, with AVGO at -19.15%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-7.67%
We cut debt repayment yoy while AVGO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-53.69%
Negative yoy issuance while AVGO is 240.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.